Report Categories Report Categories

Report Categories

industry Category

All

Total: 21 records, 3 pages

HuiJianTou lanJianTou

Global Recombinant Human Interferon Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

new_biaoQian Recombinant Human Interferon

According to our (Global Info Research) latest study, the global Recombinant Human Interferon market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

Add To Cart

Add To Cart

Global Recombinant Human Interferon α1b Supply, Demand and Key Producers, 2024-2030

date 03 Mar 2024

date Pharma & Healthcare

new_biaoQian Recombinant Human Interferon α1b

The global Recombinant Human Interferon α1b market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Recombinant Human Interferon α1b Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

new_biaoQian Recombinant Human Interferon α1b

According to our (Global Info Research) latest study, the global Recombinant Human Interferon α1b market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

Add To Cart

Add To Cart

Global Recombinant Human Interferon α2b Injection Supply, Demand and Key Producers, 2024-2030

date 15 Feb 2024

date Pharma & Healthcare

new_biaoQian Recombinant Human Interferon α2b Injection

The global Recombinant Human Interferon α2b Injection market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Recombinant Human Interferon α2b Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

new_biaoQian Recombinant Human Interferon α2b Injection

According to our (Global Info Research) latest study, the global Recombinant Human Interferon α2b Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

Add To Cart

Add To Cart

Global Recombinant Human Interferon α2a for Injection Supply, Demand and Key Producers, 2024-2030

date 15 Feb 2024

date Pharma & Healthcare

new_biaoQian Recombinant Human Interferon α2a for Injection

The global Recombinant Human Interferon α2a for Injection market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Recombinant Human Interferon α2a for Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

new_biaoQian Recombinant Human Interferon α2a for Injection

According to our (Global Info Research) latest study, the global Recombinant Human Interferon α2a for Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

Add To Cart

Add To Cart

Global Recombinant Human Interferon Supply, Demand and Key Producers, 2023-2029

date 08 Feb 2023

date Pharma & Healthcare

new_biaoQian Recombinant Human Interferon

Recombinant human interferon protein (IFN-y) is a bioactive protein primarily used for cell culture applications in many diagnostic laboratories. It is currently being used in many research activities such as immunology, oncology, stem cell research and virology. Recombinant human interferon proteins are not just limited to the process of discharging of reactive oxygen species. They are also involved in other growth functions such as bone growth and bone resorption. Recombinant human interferon protein is one of the recombinant proteins available currently, the only difference is that it is sourced from CHO-cell line. Common practice to such medium is associated with complications which might lead to failure in cell cultures. The status of recombinant human interferon protein is strictly regulated as it require strict temperature control, which is around -70°C or below for retaining full action activity. Recombinant human interferon protein is mostly available in beta and alpha form, though other forms have started emerging in the market.

USD4480.00

Add To Cart

Add To Cart

Global Recombinant Human Interferon Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 05 Jan 2023

date Pharma & Healthcare

new_biaoQian Recombinant Human Interferon

Recombinant human interferon protein (IFN-y) is a bioactive protein primarily used for cell culture applications in many diagnostic laboratories. It is currently being used in many research activities such as immunology, oncology, stem cell research and virology. Recombinant human interferon proteins are not just limited to the process of discharging of reactive oxygen species. They are also involved in other growth functions such as bone growth and bone resorption. Recombinant human interferon protein is one of the recombinant proteins available currently, the only difference is that it is sourced from CHO-cell line. Common practice to such medium is associated with complications which might lead to failure in cell cultures. The status of recombinant human interferon protein is strictly regulated as it require strict temperature control, which is around -70°C or below for retaining full action activity. Recombinant human interferon protein is mostly available in beta and alpha form, though other forms have started emerging in the market.

USD3480.00

Add To Cart

Add To Cart

Global Recombinant Human Interferon α1b Supply, Demand and Key Producers, 2023-2029

date 03 Feb 2023

date Pharma & Healthcare

new_biaoQian Recombinant Human Interferon α1b

The global Recombinant Human Interferon α1b market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

Go To Page

Confirm

industry 02 Jan 2024

industry Pharma & Healthcare

new_biaoQian Recombinant Human Interferon

According to our (Global Info Research) latest study, the global Recombinant Human Interferon market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

addToCart

Add To Cart

industry 03 Mar 2024

industry Pharma & Healthcare

new_biaoQian Recombinant Human Interferon α1b

The global Recombinant Human Interferon α1b market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 10 Jan 2024

industry Pharma & Healthcare

new_biaoQian Recombinant Human Interferon α1b

According to our (Global Info Research) latest study, the global Recombinant Human Interferon α1b market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

addToCart

Add To Cart

industry 15 Feb 2024

industry Pharma & Healthcare

new_biaoQian Recombinant Human Interferon α2b Injection

The global Recombinant Human Interferon α2b Injection market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 02 Jan 2024

industry Pharma & Healthcare

new_biaoQian Recombinant Human Interferon α2b Injection

According to our (Global Info Research) latest study, the global Recombinant Human Interferon α2b Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

addToCart

Add To Cart

The global Recombinant Human Interferon α2a for Injection market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

According to our (Global Info Research) latest study, the global Recombinant Human Interferon α2a for Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

addToCart

Add To Cart

industry 08 Feb 2023

industry Pharma & Healthcare

new_biaoQian Recombinant Human Interferon

Recombinant human interferon protein (IFN-y) is a bioactive protein primarily used for cell culture applications in many diagnostic laboratories. It is currently being used in many research activities such as immunology, oncology, stem cell research and virology. Recombinant human interferon proteins are not just limited to the process of discharging of reactive oxygen species. They are also involved in other growth functions such as bone growth and bone resorption. Recombinant human interferon protein is one of the recombinant proteins available currently, the only difference is that it is sourced from CHO-cell line. Common practice to such medium is associated with complications which might lead to failure in cell cultures. The status of recombinant human interferon protein is strictly regulated as it require strict temperature control, which is around -70°C or below for retaining full action activity. Recombinant human interferon protein is mostly available in beta and alpha form, though other forms have started emerging in the market.

USD4480.00

addToCart

Add To Cart

industry 05 Jan 2023

industry Pharma & Healthcare

new_biaoQian Recombinant Human Interferon

Recombinant human interferon protein (IFN-y) is a bioactive protein primarily used for cell culture applications in many diagnostic laboratories. It is currently being used in many research activities such as immunology, oncology, stem cell research and virology. Recombinant human interferon proteins are not just limited to the process of discharging of reactive oxygen species. They are also involved in other growth functions such as bone growth and bone resorption. Recombinant human interferon protein is one of the recombinant proteins available currently, the only difference is that it is sourced from CHO-cell line. Common practice to such medium is associated with complications which might lead to failure in cell cultures. The status of recombinant human interferon protein is strictly regulated as it require strict temperature control, which is around -70°C or below for retaining full action activity. Recombinant human interferon protein is mostly available in beta and alpha form, though other forms have started emerging in the market.

USD3480.00

addToCart

Add To Cart

industry 03 Feb 2023

industry Pharma & Healthcare

new_biaoQian Recombinant Human Interferon α1b

The global Recombinant Human Interferon α1b market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart

Go To Page

Confirm